| DBSP Home | DBSP Faculty Roster | DBSP Research Strengths |
| Grant Announcements | Achievements & Activities | Residency & Training Programs |
Roster
DBSP
Departments
VMRCVM![]() |
S. Ansar Ahmed, DVM, PhDProfessor |
| 1985 | Ph.D., School of Veterinary Studies The Murdoch University, Australia |
| 1978 | DVM (B.V.Sc) University of Agricultural Sciences, Bangalore |
| 1972 | B.Sc. The Bangalore University |
Dr. Ahmed's research program has been funded by the NIH & other agencies for more than two decades. The primary research interest in Dr. Ahmed’s laboratory is to better understand molecular aspects of inflammatory proteins (cytokine signaling) and transcription factors involved in inflammation and chronic inflammatory diseases, which afflict millions. An equally important goal is to develop innovative molecular therapies to dampen the damaging cytokine signaling pathways. This is much needed since current therapies (immunosuppressive drugs) have significant side effects. To address this central issue of inflammatory studies, his laboratory employs a variety of wild type, gene knockouts, and transgenic mice. Two different approaches to study inflammation are taken: (1) mice are exposed to a natural immunomodulator (estrogen) and (2) mice that are genetically prone to develop inflammatory autoimmune lupus. We find that treated mice and lupus-prone mice manifest heightened levels and/or response to pro-inflammatory cytokines such as interferon-γ (IFNγ) and interleukin-17 (IL-17). These cytokines while are essential to combat infections, dysregulation or exaggerated secretion/aberrant response can result in severe inflammatory diseases. We have identified key gene signaling transcription factors (cell activation proteins) and are actively designing strategies to modulate these transcription factors in an effort to contain inflammation. Another exciting project in the laboratory is to understand how naturally occurring small RNAs (microRNAs) regulate the immune system of healthy and autoimmune states. These microRNAs are known to suppress gene activation by inhibiting translation or inducing breakdown of messenger RNA. We have identified signature microRNA expression profile in mice exposed to immunomodulator (estrogen) and in genetically-lupus prone mice. Of significance is that select microRNAs can directly downregulate the induction of inflammatory biomolecules. The presence of signature micoRNA expression profile in autoimmune states is of prognostic, diagnostic and therapeutic values.
| 2008-present | Head, Department of Biomedical Sciences & Pathobiology, VMRCVM, Virginia Tech |
| 2007-2008 | Interim Head, Department of Biomedical Sciences & Pathobiology, VMRCVM, Virginia Tech |
| 2002-2007 | Director, Center for Molecular Medicine and Infectious Diseases (CMMID) VMRCVM, Virginia Tech |
| 2001-present | Professor of Immunology Department of Biomedical Sciences & Pathobiology VMRCVM, Virginia Tech |